# Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

> **NCT02182986** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 944 (actual)

## Conditions studied

- Heart Transplant
- Small Intestine Transplant
- Kidney Transplant
- Liver Transplant
- EBV-Related PTLD
- PTLDs

## Interventions

- **PROCEDURE:** transplant
- **DRUG:** Immunosuppressive Drugs

## Key facts

- **NCT ID:** NCT02182986
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-14
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 944 (ACTUAL)
- **Last updated:** 2019-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182986, "Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02182986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*